Literature DB >> 19463356

Differential healing responses in polymer- and nonpolymer-based sirolimus-eluting stents.

Michael C John1, Rainer Wessely, Adnan Kastrati, Albert Schömig, Michael Joner, Mayu Uchihashi, Johanna Crimins, Scott Lajoie, Frank D Kolodgie, Herman K Gold, Renu Virmani, Aloke V Finn.   

Abstract

OBJECTIVES: We compared the healing and inflammatory responses of polymer-free bare-metal stents (BMS), polymer-free sirolimus-eluting stents (SES) and polymer-free sirolimus-eluting stents plus estradiol (SES+ED) to Cypher drug-eluting stents (CDES) in a rabbit model of overlapping stent placement.
BACKGROUND: Inflammatory responses to polymers and delayed healing remain important safety issues associated with CDES. Whether nonpolymeric stents that elute sirolimus or sirolimus and estradiol provoke less inflammation and heal better is unknown.
METHODS: Twenty-eight rabbits received 2 overlapping stents in each iliac artery: SES, SES+ED, BMS, or CDES, and vessels were harvested at 28 days for histology and scanning electron microscopy.
RESULTS: Although similar at nonoverlapping segments, neointimal thickness within the overlap site of CDES was significantly less than in SES, SES+ED, and BMS (0.07 +/- 0.04 mm vs. 0.16 +/- 0.03 mm, 0.14 +/- 0.03 mm, and 0.15 +/- 0.03 mm, p < 0.0001). Endothelialization was greater in SES, SES+ED, and BMS compared with CDES in nonoverlapping sections (80.0 +/- 5.0% vs. 95.3 +/- 5.0%, 97.5 +/- 2.5%, and 96.7 +/- 3.8%; p = 0.0028) and overlapping sections (85.8 +/- 2.9% vs. 90.8 +/- 6.3%, 89.2 +/- 6.3%, and 48.3 +/- 2.9%; p < 0.0001). The number of luminal eosinophils was also less in overlapping sections of SES, SES+ED, and BMS versus CDES but was similar in nonoverlapping sections.
CONCLUSIONS: Polymer-free stents coated with SES or SES+ED result in less robust neointimal suppression but markedly improved arterial healing compared with CDES in the rabbit model.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19463356     DOI: 10.1016/j.jcin.2008.08.004

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN: 1936-8798            Impact factor:   11.195


  13 in total

Review 1.  Recent developments in drug-eluting stents.

Authors:  Yue Li; Ravinay Bhindi; Levon M Khachigian
Journal:  J Mol Med (Berl)       Date:  2011-01-29       Impact factor: 4.599

Review 2.  Nanotechnology in interventional cardiology.

Authors:  Tillmann Cyrus; Samuel A Wickline; Gregory M Lanza
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2011-07-11

3.  Coronary vasomotion one year after drug-eluting stent implantation: comparison of everolimus-eluting and paclitaxel-eluting coronary stents.

Authors:  Michalis Hamilos; Flavio Ribichini; Miodrag C Ostojic; Valeria Ferrero; Dejan Orlic; Corrado Vassanelli; Nevena Karanovic; Giovanna Sarno; Thomas Cuisset; Panos E Vardas; William Wijns
Journal:  J Cardiovasc Transl Res       Date:  2014-05-03       Impact factor: 4.132

4.  Long-term outcomes in patients with acute coronary syndromes related to prolonging dual antiplatelet therapy more than 12 months after coronary stenting.

Authors:  Neil J Wimmer; Alyssa B Dufour; Kelly Cho; David R Gagnon; Lien Quach; Samantha Ly; Jacquelyn-My Do; Simon Ostrowski; J Michael Gaziano; David P Faxon; Scott Kinlay
Journal:  Catheter Cardiovasc Interv       Date:  2016-11-10       Impact factor: 2.692

5.  Everolimus-eluting stents improve vascular response in a diabetic animal model.

Authors:  Anwer Habib; Vinit Karmali; Michael C John; Rohini Polavarapu; Gaku Nakazawa; Kim Pachura; Talina Davis; Frank D Kolodgie; Renu Virmani; Aloke V Finn
Journal:  Circ Cardiovasc Interv       Date:  2014-06-10       Impact factor: 6.546

6.  Effect of anti-ApoA-I antibody-coating of stents on neointima formation in a rabbit balloon-injury model.

Authors:  Aart C Strang; Menno L W Knetsch; Leo H Koole; Robbert J de Winter; Allard C van der Wal; Carlie J M de Vries; Paul P Tak; Radjesh J Bisoendial; Erik S G Stroes; Joris I Rotmans
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

Review 7.  Prevention of stent thrombosis: challenges and solutions.

Authors:  Risheen Reejhsinghani; Amir S Lotfi
Journal:  Vasc Health Risk Manag       Date:  2015-01-27

8.  Polymer-free dual drug-eluting stents evaluated in a porcine model.

Authors:  Bin Zhang; Bo Zheng; Xingang Wang; Qiuping Shi; Jia Jia; Yong Huo; Chunshui Pan; Jingyan Han; Ming Chen
Journal:  BMC Cardiovasc Disord       Date:  2017-08-15       Impact factor: 2.298

9.  Aneurysmal degeneration of fluoropolymer-coated paclitaxel-eluting stent in the superficial femoral artery: a rising concern.

Authors:  Takuya Tsujimura; Osamu Iida; Mitsutoshi Asai; Masaharu Masuda; Shin Okamoto; Takayuki Ishihara; Kiyonori Nanto; Takashi Kanda; Yasuhiro Matsuda; Yosuke Hata; Hiroyuki Uematsu; Taku Toyoshima; Naoko Higashino; Toshiaki Mano
Journal:  CVIR Endovasc       Date:  2021-07-03

10.  Next generation drug-eluting stents: focus on bioabsorbable platforms and polymers.

Authors:  Brendan Doyle; David R Holmes
Journal:  Med Devices (Auckl)       Date:  2009-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.